News

Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 29 May 2026, inter alia, have recommended the final dividend of Rs 6 per equity Share (i.e. 600%) , subject to the approval of the shareholders.

Net profit of Ipca Laboratories rose 340.98% to Rs 299.07 crore in the quarter ended March 2026 as against Rs 67.82 crore during the previous quarter ended March 2025. Sales rose 6.31% to Rs 2388.48 crore in the quarter ended March 2026 as against Rs 2246.69 crore during the previous quarter ended March 2025.For the full year,net profit rose 54.69% to Rs 1141.12 crore in the year ended March 2026 as against Rs 737.68 crore during the previous year ended March 2025. Sales rose 7.91% to Rs 9646.33 crore in the year ended March 2026 as against Rs 8939.59 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales2388.482246.69 6 9646.338939.59 8 OPM %20.2619.09 -20.5119.31 - PBDT557.41433.17 29 2077.071734.01 20 PBT450.27333.05 35 1658.951336.19 24 NP299.0767.82 341 1141.12737.68 55 Powered by Capital Market - Live News

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net profit of Ipca Laboratories rose 31.49% to Rs 326.27 crore in the quarter ended December 2025 as against Rs 248.14 crore during the previous quarter ended December 2024. Sales rose 6.55% to Rs 2392.50 crore in the quarter ended December 2025 as against Rs 2245.37 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales2392.502245.37 7 OPM %22.2920.62 - PBDT535.92466.38 15 PBT428.33367.92 16 NP326.27248.14 31 Powered by Capital Market - Live News

Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News